Table 2.

Dermatoscopic features of the 20 lesions prior to initiation of therapy and at weeks 4 and 8 after treatment with imiquimod

	ARBORIZING VESSELS	ULCERATION	BLUE-GRAY GLOBULES	OVOID NESTS	LEAF-LIKE AREAS	SPOKE WHEEL AREAS
Patient 1	+	-	+	+	-	-
W#4	R		R	R
W#8	C		C	C
Patient 2	-	-	-	-	+	-
W#4					R
W#8					C
Patient 3	+	-	+	+	-	-
W#4	R		C	R
W#8	C		C	C
Patient 4	+	+	+	+	-	-
W#4	C	C	C	R
W#8	C	C	C	C
Patient 5	-	+	+	+	+	-
W#4		C	C	R	C
W#8		C	C	C	C
Patient 6	+	-	-	+	-	-
W#4	R			R
W#8	R			R
Patient 7	+	-	-	+	-	-
W#4	C			C
W#8	C			C
Patient 8	+	-	+	-	-	-
W#4	C		C
W#8	C		C
Patient 9	-	+	+	+	-	-
W#4		C	R	R
W#8		C	C	C
Patient 10	-	-	+	-	+
W#4			R		R
W#8			C		C
Patient 11	-	+	+	-	+	-
W#4		C	R		R
W#8		C	C		C
Patient 12	+	-	+	+	-	-
W#4	C		C	R
W#8	C		C	C
Patient 13	-	-	-	+	+	-
W#4				R	R
W#8				C	C
Patient 14	+	-	-	+	+	-
W#4	C			R	R
W#8	C			C	C
Patient 15	+	-	-	+	-	-
W#4	C			R
W#8	C			C
Patient 16	+	+	+	+	-	-
W#4	C	C	R	R
W#8	C	C	C	C
Patient 17	-	+	-	+	-	-
W#4		C		R
W#8		C		C
Patient 18	+	-	-	+	-	-
W#4	R			R
W#8	C			C
Patient 19	+	+	-	+	-	-
W#4	C	C		R
W#8	C	C		C
Patient 20	+	+	-	+	-	-
W#4	C	C		R
W#8	C	C		C

R: Response of features (decrease in number and/or intensity). C: clearance (complete clearance of features)